Pharmatek Opens New HP/Cyto-Manufacturing Facility

Pharmatek has opened its highly-potent and cytotoxic facility in San Diego, CA. The 18,000-sq.-ft. facility includes newly constructed analytical and formulation development labs and cGMP manufacturing suites for the development of highly-potent and cytotoxic drug product for early phase clinical trials.
   
The facility holds a State of California Food and Drug Branch (FDB) Drug Manufacturers License and is currently working on several highly-potent development projects. The FDB license authorizes Pharmatek to manufacture and ship clinical material from its manufacturing and development site.
   
“Highly-potent and cytotoxic compounds are among the most sensitive drugs to handle and produce,” said Kevin Rosenthal, director of manufacturing of Pharmatek. “Our primary goal when designing the facility was to optimize product quality while ensuring operator safety to guarantee our clients’ drug candidates move smoothly from discovery to clinical trials.”